BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 250 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $605,000 | +3.8% | 4,000 | 0.0% | 0.26% | +13.3% |
| Q2 2022 | $583,000 | +23.0% | 4,000 | 0.0% | 0.23% | +49.4% |
| Q1 2022 | $474,000 | -14.0% | 4,000 | 0.0% | 0.16% | -7.1% |
| Q4 2021 | $551,000 | -0.9% | 4,000 | 0.0% | 0.17% | -8.2% |
| Q3 2021 | $556,000 | +43.3% | 4,000 | 0.0% | 0.18% | +45.2% |
| Q2 2021 | $388,000 | +42.1% | 4,000 | 0.0% | 0.13% | +32.6% |
| Q1 2021 | $273,000 | -20.4% | 4,000 | 0.0% | 0.10% | -25.2% |
| Q4 2020 | $343,000 | +31.9% | 4,000 | 0.0% | 0.13% | +16.5% |
| Q3 2020 | $260,000 | -11.0% | 4,000 | 0.0% | 0.11% | -18.0% |
| Q2 2020 | $292,000 | +33.9% | 4,000 | 0.0% | 0.13% | +47.8% |
| Q4 2019 | $218,000 | – | 4,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $154,344,000 | 72.03% |
| Knoll Capital Management, LLC | 856,844 | $119,024,000 | 59.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,124,055 | $295,053,000 | 36.73% |
| ARS Investment Partners, LLC | 466,668 | $64,825,000 | 6.49% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 365,373 | $50,754,000 | 6.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $24,490,000 | 5.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 61,897 | $8,598,000 | 4.86% |
| DAFNA Capital Management LLC | 88,100 | $12,238,000 | 3.25% |
| Avidity Partners Management LP | 934,200 | $129,770,000 | 2.88% |
| Eventide Asset Management | 1,325,000 | $184,056,000 | 2.43% |